Тактика ведения женщин с приступами мигрени во время беременности

1. GBD 2015 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016; 388(10053): 1545-602. doi: 10.1016/S0140-6736(16)31678-6
2. Tietjen G.E., Collins S.A. Hypercoagulability and migraine. Headache. 2018; 58(1): 173-83. http://dx.doi.org/10.1111/head.13044
3. Bakar N.A., Tanprawate S., Lambru G., Torkamani M., Jahanshahi M., Matharu M. Quality of life in primary headache disorders: a review. Cephalalgia. 2016; 36(1): 67-91. doi: 0.1177/0333102415580099
4. Steiner T.J., Birbeck G.L., Jensen R.H., Zaza Katsarava Z., Stovner L.J., Martelletti P. Headache disorders are third cause of disability worldwide. J. Headache Pain. 2015; 16: 58. doi: 10.1186/s10194-015-0544-2
5. Екушева Е.В., Дамулин И.В. Мигренозные приступы во время беременности: тактика ведения пациенток и приоритеты терапии. Российский медицинский журнал. 2014; 3: 41-8.
6. MacGregor А. Menstrual migraine, migraine and contraceptions, migraine and pregnancy and migraine triggers. J. Headache Pain. 2013; 14(Suppl.1): O5. doi: 10.1186/1129-2377-1-S1-O5
7. Contag S.A., Mertz H.L., Bushnell C.D. Migraine during pregnancy: is it more than a headache? Nat. Rev. Neurol. 2009; 5(8): 449-56. doi: 10.1038/nrneurol.2009.100
8. Elliott D., Li X., Zhu P., Gaitour E. Headache in pregnancy. In: Minagar A., ed. Neurological disorders and pregnancy. London: Elsevier; 2011: 19-37. doi: 10.1016/b978-0-12-384911-3.00002-6
9. Goadsby P.J., Goldenberg J., Silberstein S.D. Migraine in pregnancy. BMJ. 2008; 336(7659): 1502-4. doi: 10.1136/bmj.39559.675891.ad
10. Bigal M.E., Lipton R.B. The epidemiology, burden, and comorbidities of migraine. Neurol. Clin. 2009; 27(2): 321-34. doi: 10.1016/j.ncl.2008.11.011
11. Kvisvik E.V., Stovner L.J., Helde G., Bovim G., Linde M. Headache and migraine during pregnancy and puerperium: the MIGRA-study. J. Headache Pain. 2011; 12(4): 443-51. doi: 10.1007/s10194-011-0329-1
12. Ertresvåg J.M., Stovner L.J., Kvavik L.E., Johnsen H.-J., Zwart J.-A., Helde G. et al. Migraine aura or transient ishemic attaks? A five-year follow-up case-control study of women with transient central nervous system disorders in pregnancy. BMJ Medicine. 2007; 5: 19-26. doi: 10.1186/1741-7015-5-19/
13. Turner D.P., Smitherman T.A., Eisenach J.C., Penzien D.B., Houle T.T. Predictors of headache before, during, and after pregnancy: a cohort study. Headache. 2012; 52(3): 348-62. doi: 10.1111/j.1526-4610.2011.02066.x
14. MacGregor E.A. Estrogen and migraine: correlations and prevention. Headache. 2008; 48(Suppl. 2): S99-107. doi: 10.1111/j.1526-4610.2008.01202.x
15. Duong S., Bozzo P., Nordeng H., Einarson A. Safety of triptans for migraine headaches during pregnancy and breastfeeding. Can. Fam. Physician. 2010; 56(6): 537-9.
16. Serva W.A., Serva V.M., Caminha M.F.C., Figueiroa J.N., Albuquerque E.C., Serva G.B.D. et al. Course of migraine during pregnancy among migraine sufferers before pregnancy. Arq. Neuropsiquiatr. 2011; 69(4): 613-9. doi: 10.1590/s0004-282x2011000500008
17. Jalilian N., Fakheri T., Daeichin S., Vakilifar F. Migraine management in pregnancy. J. Inj. Violence Res. 2012; 4(3, Suppl.1): 78.
18. Calhoun A.H. Migraine treatment in pregnancy and lactation. Curr. Pain Headache Rep. 2017; 21(11): 46. doi: 10.1007/s11916-017-0646-4.
19. Soldin O.P., Dahlin J., O'Mara D.M. Triptans in pregnancy. Ther. Drug Monit. 2008; 30(1): 5-9. doi: 10.1097/ftd.0b013e318162c89b.
20. Marcus D.A. Managing headache during pregnancy and lactation. Expert Rev. Neurother. 2008; 8(3): 385-95. doi: 10.1586/14737175.8.3.385
21. Nappi R.E., Albani F., Sances G., Terreno E., Brambilla E., Polatti F. Headaches during pregnancy. Curr. Pain Headache Rep. 2011; 15(4): 289-94. doi: 10.1007/s11916-011-0200-8
22. Amundsen S., Nordeng H., Nezvalova-Henriksen K., Stovner L.J., Spigset O. Pharmacological treatment of migraine during pregnancy and breastfeeding. Nat. Rev. Neurol. 2015; 11: 209-19. doi: 10.1038/nrneurol.2015.29
23. Liberman A., Karussis D., Ben-Hur T., Abramsky O., Leker R.R. Natural course and pathogenesis of transient focal neurologic symptoms during pregnancy. Arch. Neurol. 2008; 65(2): 218-20. doi: 10.1001/archneurol.2007.50
24. Chen S.P., Fuh J.L., Wang S.J. Reversible cerebral vasoconstriction syndrome: current and future perspectives. Expert Rev. Neurother. 2011; 11(9): 1265-76. doi: 10.1586/ern.11.112
25. Allais G., Gabellari I.C., Borgogno P., Lorenzo C.D., Benedetto C. The risks of women with migraine during pregnancy. Neurol. Sci. 2010; 31(Suppl. 1): S59-61. doi: 10.1007/s10072-010-0274-9
26. Hosley C.M., McCullough L.D. Acute neurological issues in pregnancy and the peripartum. The Neurohospitalist. 2011; 1(2): 104-16. doi: 10.1177/1941875211399126
27. Kanal E., Barkovich A.J., Bell C., Borgstede J.P., Bradley W.G., Froelich J.W. et al.; Expert panel on MR safety. ACR guidance document on MR safe practices: 2013. J. Magn. Reson. Imaging. 2013; 37(3): 501-30. doi: 10.1002/jmri.24011
28. Damak M., Crassard I., Wolf V., Bousser M.-G. Isolated lateral sinus thrombosis. A series of 62 patients. Stroke. 2009; 40(2): 476-81. doi: 10.1161/strokeaha.107.509711
29. Екушева Е.В., Дамулин И.В. Современные подходы к терапии мигрени во время беременности. Журнал неврологии и психиатрии имени С.С. Корсакова. 2015; 115(11): 124-32.
30. Wabnitz A., Bushnell C. Migraine, cardiovascular disease, and stroke during pregnancy: systematic review of the literature. Cephalalgia. 2015; 35(2): 132-9. https://doi.org/10.1177/0333102414554113
31. MacGregor A. Management of migraine during pregnancy. Progr. Neurol. Psychiatr. 2009; 13(5): 21-4. https://doi.org/10.1002/pnp.137
32. Evans E.W., Lorber K.C. Use of 5-HT1 agonists in pregnancy. Ann. Pharmacother. 2008; 42(4): 543-9. doi: 10.1345/aph.1k176
33. Bobker S., Klebanoff L., Broner S. Migraine in women. Neurology. 2017; 37(6): 601-10. https://doi.org/10.1055/s-0037-1607393
34. Nezvalová-Henriksen K., Spigset O., Nordeng H. Triptan safety during pregnancy: a Norwegian population registry study. Eur. J. Epidemiol. 2013; 28(9): 759-69. doi: 10.1007/s10654-013-9831-x
35. Negro A., Delaruelle Z., Ivanova T.A., Khan S., Ornello R., Raffaelli B. et al. Headache and pregnancy: a systematic review. J. Headache Pain. 2017; 18(1):106. https://doi.org/10.1186/s10194-017-0816-0
36. Chen H.M., Chen S.F., Chen Y.H., Lin H.C. Increased risk of adverse pregnancy outcomes for women with migraines: a nationwide population-based study. Cephalalgia. 2009; 30(4): 433-8. https://doi.org/10.1111/j.1468-2982.2009.01935.x
37. Menon R., Bushnell C.D. Headache and pregnancy. Neurologist. 2008; 14(2): 108-19. doi: 10.1097/nrl.0b013e3181663555
38. Amundsen S., Øvrebø T.G., Amble N.M.S., Poole A.C., Nordeng H. Use of antimigraine medications and information needs during pregnancy and breastfeeding: a cross-sectional study among 401 Norwegian women. Eur. J. Clin. Pharmacol. 2016; 72(12): 1525-35. doi: 10.1007/s00228-016-2127-9
39. Екушева Е.В. Оптимальные подходы к купированию приступа мигрени: прошлое, настоящее и будущее. Русский медицинский журнал. 2012; 20(10): 522-8.
40. Nijjar S.S., Rosenberg J., Peterlin B.L. Migraine in women. In: Chin M.L., Fillingim R.B., Ness T.J., eds. Pain in women. New York: Oxford University Press; 2010: 297-309. doi: 10.1093/med/9780199796410.003.0021

Поступила 06.04.2018

Принята в печать 20.04.2018